As summarized in Fig. 8, we therefore proposed that phytosomal curcumin may exert its chemopreventive effects on HBV-related HCC, at least in part, through the following three mechanisms: First, phytosomal curcumin may act as an agonist to activate PPARγ. The gene discussed is PPARG; the disease is hepatocellular carcinoma.